Mucopolysaccharidosis Type IVa (Morquio Syndrome) Clinical Features and Management: Case Report
DOI:
https://doi.org/10.33425/2690-5191.1129Keywords:
Mucopolysaccharidosis, Morquio syndrome, Skeletal abnormalities, Lysosomal storage disorder, GlycosaminoglycansAbstract
Mucopolysaccharidosis type IV A (MPS IV A), often referred to as Morquio syndrome, is a rare genetic disease characterised by an autosomal recessive deficiency in N-acetylgalactosamine-6-sulfatase (GALNS), which results in the accumulation of glycosaminoglycans within cells. Treating individuals with this condition with enzyme replacement therapy has proven to be essential. Radiographic imaging, clinical evaluation, and biochemical testing are used to diagnose MPS IV A. Notable skeletal anomalies, aberrant joint mobility, severe growth impairment, dental misalignment, and defects in the enamel are the characteristics of the disorder. This clinical case report details the dental care provided to a sevenyear-old Saudi Arabian girl with many bone anomalies.
Published
Issue
Section
License
Copyright (c) 2025 Medicine and Clinical Science

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.